The Risk of Pneumothorax With Intrapleural Urokinase in Children With Parapneumonic Effusion

Fibrinolytic therapy is commonly used in children with parapneumonic effusion, to facilitate drainage of the effusions and recovery. However, data regarding complications of this treatment in children are limited. We aimed to determine the incidence of pneumothorax (PNX) associated with intrapleural...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric pulmonology 2024-12, p.e27443
Main Authors: Kadmon, Gili, Schoen, Adi, Nahum, Elhanan, Weissbach, Avichai, Kaplan, Eytan, Cohen, Tal, Chodick, Gabriel, Scheuerman, Oded
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fibrinolytic therapy is commonly used in children with parapneumonic effusion, to facilitate drainage of the effusions and recovery. However, data regarding complications of this treatment in children are limited. We aimed to determine the incidence of pneumothorax (PNX) associated with intrapleural urokinase. We analyzed retrospectively collected data of children with parapneumonic effusion who underwent chest drain insertion. The clinical course and complications, including the incidence of PNX, were compared between children who were and were not treated with urokinase. The study group included 120 children, of whom 57 were treated with urokinase. Children who were and were not treated with urokinase did not differ in markers of disease severity or in the length of hospitalization. Among the patients treated with urokinase compared to those not treated, the incidence of PNX was higher (35% vs. 6%, p 
ISSN:1099-0496
1099-0496
DOI:10.1002/ppul.27443